
Actively managed fund
Polar Capital Biotech I GBP Hdg Inc
- ISIN
- IE00BFX4HX56
- Category
- Other Equity
How good is this fund, really?
See the rating in the appAbout Polar Capital Biotech I GBP Hdg Inc
Biotechnology, diagnostics and life sciences tools companies from around the world make up Polar Capital Biotechnology, which aims to preserve capital and achieve long-term growth. The portfolio is spread across countries, biotech sub-sectors and company sizes. Active management targets the NASDAQ Biotechnology Net Total Return Index (USD), which is also the hurdle for a performance fee of 10% of returns above it; for this class that fee came to 0.82% in the year to 31 December 2025. The ongoing charge is 1.10%. Class I Hedged GBP Distribution shares may pay an annual dividend at the directors' discretion. The fund launched on 31 October 2013 and this class on 16 January 2018. It is an SFDR Article 8 fund rated 6 out of 7 for risk, with a recommended horizon of five years or more.
Watch this fund for free Add Polar Capital Biotech I GBP Hdg Inc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.
Watch the fund for freeWhere to buy Polar Capital Biotech I GBP Hdg Inc — platforms and fees
Sold on 2 platforms we follow.
-
AJ Bell Annual fee: See the platformGo to AJ Bell ↗
-
Fidelity Annual fee: See the platformGo to Fidelity ↗
Polar Capital Biotech I GBP Hdg Inc — its category
Other Equity — PowerFunds rates 2,983 funds in this category every month.
Other equity funds →Other funds
- PGIM Jennison US Growth GBP H L Acc
- Pictet Longevity (Class I)
- Pictet-Japanese Equity Opps HI GBP
- Pictet-Japanese Equity Sel HI GBP
- Pictet-Russian Equities I GBP
- PIMCO GIS MLP & Energy Infrastructure (Inst Hgd)
- Polar Capital Global Ins I USD Hdg Acc
- Polar Capital Global Ins Ptf CcyHIGBPInc
- Polar Capital Global Tech I GBP Hdg Inc
- Polar Capital Japan Value R Sterling Hdg
- Polar Capital Japan Value S Sterling Hdg
- Polar Capital North American I GBP Hdg